1. Home
  2. GOSS
  3. GOSS News

Latest Gossamer Bio Inc. (GOSS) News on March 26, 2025

Gossamer Bio (GOSS): Among the Penny Stocks With Huge Upside Potential According to Analysts
GOSS

Insider Monkey

3 days ago

Gossamer Bio (GOSS): Among the Penny Stocks With Huge Upside Potential According to Analysts

Gossamer Bio (GOSS) Reports Q4 Loss, Tops Revenue Estimates
GOSS

Zacks

13 days ago

Gossamer Bio (GOSS) Reports Q4 Loss, Tops Revenue Estimates

GOSS

Associated Press Finance

13 days ago

Gossamer Bio: Q4 Earnings Snapshot

Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
GOSS

Business Wire

13 days ago

Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

3 Promising Penny Stocks With Over $100M Market Cap
GOSS

Simply Wall St.

14 days ago

3 Promising Penny Stocks With Over $100M Market Cap

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GOSS

Business Wire

19 days ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

With 60% ownership of the shares, Gossamer Bio, Inc. (NASDAQ:GOSS) is heavily dominated by institutional owners
GOSS

Simply Wall St.

23 days ago

With 60% ownership of the shares, Gossamer Bio, Inc. (NASDAQ:GOSS) is heavily dominated by institutional owners

Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now
GOSS

GlobeNewswire

a month ago

Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GOSS

Business Wire

2 months ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress
GOSS

Business Wire

2 months ago

Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

Gossamer Bio And 2 Other Promising Penny Stocks On US Exchanges
GOSS

Simply Wall St.

2 months ago

Gossamer Bio And 2 Other Promising Penny Stocks On US Exchanges

Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress
GOSS

Business Wire

2 months ago

Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GOSS

Business Wire

3 months ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Why Gossamer Bio, Inc. (GOSS) Is Among the Best Penny Stocks to Invest In According to Media?
GOSS

Insider Monkey

3 months ago

Why Gossamer Bio, Inc. (GOSS) Is Among the Best Penny Stocks to Invest In According to Media?

3 US Penny Stocks With Market Caps Over $100M
GOSS

Simply Wall St.

3 months ago

3 US Penny Stocks With Market Caps Over $100M

Gossamer Bio (GOSS) Upgraded to Buy: Here's What You Should Know
GOSS

Zacks

3 months ago

Gossamer Bio (GOSS) Upgraded to Buy: Here's What You Should Know

US Penny Stocks: 3 Picks With Market Caps Under $200M
GOSS

Simply Wall St.

4 months ago

US Penny Stocks: 3 Picks With Market Caps Under $200M

All You Need to Know About Gossamer Bio (GOSS) Rating Upgrade to Buy
GOSS

Zacks

4 months ago

All You Need to Know About Gossamer Bio (GOSS) Rating Upgrade to Buy

After Plunging -20% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)
GOSS

Zacks

4 months ago

After Plunging -20% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)

After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)
GOSS

Zacks

4 months ago

After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)

Industry Analysts Just Made A Sizeable Upgrade To Their Gossamer Bio, Inc. (NASDAQ:GOSS) Revenue Forecasts
GOSS

Simply Wall St.

4 months ago

Industry Analysts Just Made A Sizeable Upgrade To Their Gossamer Bio, Inc. (NASDAQ:GOSS) Revenue Forecasts

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GOSS

Business Wire

4 months ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets
GOSS

Simply Wall St.

5 months ago

Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets

Gossamer Bio (GOSS) Reports Q3 Loss, Tops Revenue Estimates
GOSS

Zacks

5 months ago

Gossamer Bio (GOSS) Reports Q3 Loss, Tops Revenue Estimates

GOSS

Associated Press Finance

5 months ago

Gossamer Bio: Q3 Earnings Snapshot

Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update
GOSS

Business Wire

5 months ago

Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update

NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule
GOSS

GlobeNewswire

5 months ago

NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule

Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now
GOSS

GlobeNewswire

5 months ago

Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now

Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now
GOSS

GlobeNewswire

5 months ago

Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now

3 US Penny Stocks With Market Caps Under $900M To Consider
GOSS

Simply Wall St.

5 months ago

3 US Penny Stocks With Market Caps Under $900M To Consider

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GOSS

Business Wire

6 months ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Several Insiders Invested In Gossamer Bio Flagging Positive News
GOSS

Simply Wall St.

6 months ago

Several Insiders Invested In Gossamer Bio Flagging Positive News

Presenting on the Emerging Growth Conference 75 Day 2 on September 26
GOSS

GlobeNewswire

6 months ago

Presenting on the Emerging Growth Conference 75 Day 2 on September 26

Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024
GOSS

Business Wire

7 months ago

Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024

Presenting on the Emerging Growth Conference 74 Day 2 on August 22 Register Now
GOSS

GlobeNewswire

7 months ago

Presenting on the Emerging Growth Conference 74 Day 2 on August 22 Register Now

Analysts Just Made A Notable Upgrade To Their Gossamer Bio, Inc. (NASDAQ:GOSS) Forecasts
GOSS

Simply Wall St.

7 months ago

Analysts Just Made A Notable Upgrade To Their Gossamer Bio, Inc. (NASDAQ:GOSS) Forecasts

With 73% institutional ownership, Gossamer Bio, Inc. (NASDAQ:GOSS) is a favorite amongst the big guns
GOSS

Simply Wall St.

7 months ago

With 73% institutional ownership, Gossamer Bio, Inc. (NASDAQ:GOSS) is a favorite amongst the big guns

Gossamer Bio (GOSS) Q2 Earnings and Revenues Lag Estimates
GOSS

Zacks

7 months ago

Gossamer Bio (GOSS) Q2 Earnings and Revenues Lag Estimates

GOSS

Associated Press Finance

7 months ago

Gossamer Bio: Q2 Earnings Snapshot

Gossamer Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
GOSS

Business Wire

7 months ago

Gossamer Bio Announces Second Quarter 2024 Financial Results and Provides Business Update

Why Is Gossamer Bio, Inc. (GOSS) the Best One-Dollar Stock to Buy Now?
GOSS

Insider Monkey

8 months ago

Why Is Gossamer Bio, Inc. (GOSS) the Best One-Dollar Stock to Buy Now?

GOSS

MT Newswires

9 months ago

Oppenheimer Initiates Gossamer Bio at Outperform With $9 Price Target

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
GOSS

GOBankingRates

10 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller
GOSS

AFP

10 months ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up
GOSS

AFP

10 months ago

Italy beat Bosnia in final Euros warm-up

Trump loyalists proud to support 'felon' at Las Vegas rally
GOSS

AFP

10 months ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
GOSS

Business Insider

10 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
GOSS

Insider Monkey

10 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
GOSS

Reuters

10 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

GOSS

Insider Monkey

10 months ago

Best Date Night Fragrance in 2024

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GOSS

Business Wire

10 months ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference
GOSS

Business Wire

10 months ago

Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GOSS

Business Wire

a year ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GOSS

Associated Press Finance

a year ago

Gossamer Bio: Q1 Earnings Snapshot

Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
GOSS

Business Wire

a year ago

Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update

Gossamer Bio and Chiesi partner for pulmonary hypertension treatment
GOSS

Pharmaceutical Technology

a year ago

Gossamer Bio and Chiesi partner for pulmonary hypertension treatment

Gossamer Bio and Chiesi link for pulmonary hypertension treatment
GOSS

Pharmaceutical Technology

a year ago

Gossamer Bio and Chiesi link for pulmonary hypertension treatment

Gossamer Bio Collaborates With Italian Drugmaker Chiesi To Advance Lung Health Solutions Worldwide
GOSS

Benzinga

a year ago

Gossamer Bio Collaborates With Italian Drugmaker Chiesi To Advance Lung Health Solutions Worldwide

GOSS

Reuters

a year ago

UPDATE 1-Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition

Gossamer sells rights to drug it hopes can rival a new Merck therapy
GOSS

BioPharma Dive

a year ago

Gossamer sells rights to drug it hopes can rival a new Merck therapy

GOSS

Reuters

a year ago

Gossamer Bio and Chiesi Group to collaborate for blood pressure treatment

Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications
GOSS

Business Wire

a year ago

Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications

Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine
GOSS

Business Wire

a year ago

Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine

Gossamer Bio Decline Means Insider Profits Down To US$17k
GOSS

Simply Wall St.

a year ago

Gossamer Bio Decline Means Insider Profits Down To US$17k

13 Best Biotech Stocks To Buy Under $20
GOSS

Insider Monkey

a year ago

13 Best Biotech Stocks To Buy Under $20

Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
GOSS

Business Wire

a year ago

Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors

Should You Buy Gossamer Bio (GOSS) After Golden Cross?
GOSS

Zacks

a year ago

Should You Buy Gossamer Bio (GOSS) After Golden Cross?

GOSS

Associated Press Finance

a year ago

Gossamer Bio: Q4 Earnings Snapshot

Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
GOSS

Business Wire

a year ago

Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

12 Best Medical Stocks to Buy Under $10
GOSS

Insider Monkey

a year ago

12 Best Medical Stocks to Buy Under $10

SurModics (SRDX) Reports Break-Even Earnings for Q1
GOSS

Zacks

a year ago

SurModics (SRDX) Reports Break-Even Earnings for Q1

WestRock (WRK) Q1 Earnings and Revenues Miss Estimates
GOSS

Zacks

a year ago

WestRock (WRK) Q1 Earnings and Revenues Miss Estimates

7 Micro-Cap Stocks That Could Majorly Surprise Investors
GOSS

InvestorPlace

a year ago

7 Micro-Cap Stocks That Could Majorly Surprise Investors

loanDepot’s Dan Hanson inducted to California Homebuilding Foundation’s Hall of Fame
GOSS

Business Wire

a year ago

loanDepot’s Dan Hanson inducted to California Homebuilding Foundation’s Hall of Fame

ibex Launches Wave iX: The Next Evolution in AI-Powered Digital-First Customer Experience
GOSS

GlobeNewswire

a year ago

ibex Launches Wave iX: The Next Evolution in AI-Powered Digital-First Customer Experience

Greenfire Resources Announces Operational Update, Including Strong Initial Refill Well Results and New WTI Hedging Program
GOSS

Newsfile

a year ago

Greenfire Resources Announces Operational Update, Including Strong Initial Refill Well Results and New WTI Hedging Program

LINKBANCORP, Inc. Announces Fourth Quarter 2023 and Full Year 2023 Financial Results
GOSS

PR Newswire

a year ago

LINKBANCORP, Inc. Announces Fourth Quarter 2023 and Full Year 2023 Financial Results

Owning 37% shares,institutional owners seem interested in NexPoint Real Estate Finance, Inc. (NYSE:NREF),
GOSS

Simply Wall St.

a year ago

Owning 37% shares,institutional owners seem interested in NexPoint Real Estate Finance, Inc. (NYSE:NREF),

Heron Therapeutics, Inc. (NASDAQ:HRTX) is largely controlled by institutional shareholders who own 52% of the company
GOSS

Simply Wall St.

a year ago

Heron Therapeutics, Inc. (NASDAQ:HRTX) is largely controlled by institutional shareholders who own 52% of the company

Mid Penn Bank Promotes Jordan Space to President of the Private Bank and Chief Operating Officer of the Company
GOSS

Business Wire

a year ago

Mid Penn Bank Promotes Jordan Space to President of the Private Bank and Chief Operating Officer of the Company

Rackspace Technology Introduces AI Anywhere, a Cutting-edge Private Cloud Solution Harnessing the Power of Artificial Intelligence and Machine Learning in a Secure Hosting Environment
GOSS

GlobeNewswire

a year ago

Rackspace Technology Introduces AI Anywhere, a Cutting-edge Private Cloud Solution Harnessing the Power of Artificial Intelligence and Machine Learning in a Secure Hosting Environment

Alpine Income Property Trust Announces Fourth Quarter 2023 Earnings Release and Conference Call Information
GOSS

GlobeNewswire

a year ago

Alpine Income Property Trust Announces Fourth Quarter 2023 Earnings Release and Conference Call Information

The 3 Most Undervalued Biotech Stocks to Buy in January
GOSS

InvestorPlace

a year ago

The 3 Most Undervalued Biotech Stocks to Buy in January

Q3 Rundown: WalkMe (NASDAQ:WKME) Vs Other Sales And Marketing Software Stocks
GOSS

StockStory

a year ago

Q3 Rundown: WalkMe (NASDAQ:WKME) Vs Other Sales And Marketing Software Stocks

This Forum Energy Technologies Insider Increased Their Holding By 22% Last Year
GOSS

Simply Wall St.

a year ago

This Forum Energy Technologies Insider Increased Their Holding By 22% Last Year

MISTRAS Group to Participate in Sidoti Micro-Cap Virtual Investor Conference on January 17-18, 2024
GOSS

GlobeNewswire

a year ago

MISTRAS Group to Participate in Sidoti Micro-Cap Virtual Investor Conference on January 17-18, 2024

Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream
GOSS

GlobeNewswire

a year ago

Presenting on Emerging Growth Conference 66 Day 2 on January 11 Register to Stream

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GOSS

Business Wire

a year ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

New Strong Sell Stocks for January 8th
GOSS

Zacks

a year ago

New Strong Sell Stocks for January 8th

Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry's First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma
GOSS

GlobeNewswire

a year ago

Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry's First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma

Sutro Biopharma Highlights Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeting ADC
GOSS

GlobeNewswire

a year ago

Sutro Biopharma Highlights Potential Multi-Cancer Opportunity for Luvelta, a FolRα-targeting ADC

3 Communication Stocks Likely to Sail Against Industry Odds
GOSS

Zacks

a year ago

3 Communication Stocks Likely to Sail Against Industry Odds

Nano Dimension Announces Record Fourth Quarter and Full Year 2023 Preliminary Results
GOSS

GlobeNewswire

a year ago

Nano Dimension Announces Record Fourth Quarter and Full Year 2023 Preliminary Results

JOHN HANCOCK CLOSED-END FUNDS DECLARE MONTHLY DISTRIBUTIONS
GOSS

PR Newswire

a year ago

JOHN HANCOCK CLOSED-END FUNDS DECLARE MONTHLY DISTRIBUTIONS

Could Nano Dimension Stock Print New Millionaire Investors in 2024?
GOSS

Motley Fool

a year ago

Could Nano Dimension Stock Print New Millionaire Investors in 2024?

Is it a Good Idea to Sell Sterling Bancorp (SBT) Now?
GOSS

Insider Monkey

a year ago

Is it a Good Idea to Sell Sterling Bancorp (SBT) Now?

Will Garmin Ltd. (GRMN) Face Stiffer Competition?
GOSS

Insider Monkey

a year ago

Will Garmin Ltd. (GRMN) Face Stiffer Competition?

Luna Acquires Silixa
GOSS

Business Wire

a year ago

Luna Acquires Silixa

Consolidated Communications Files Letter to Shareholders Highlighting Benefits of Proposed Transaction with Searchlight and BCI
GOSS

Business Wire

a year ago

Consolidated Communications Files Letter to Shareholders Highlighting Benefits of Proposed Transaction with Searchlight and BCI

Verastem Oncology Selects Oral KRAS G12D Inhibitor GFH375/VS-7375 as Lead Program in Discovery and Development Collaboration with GenFleet Therapeutics
GOSS

Business Wire

a year ago

Verastem Oncology Selects Oral KRAS G12D Inhibitor GFH375/VS-7375 as Lead Program in Discovery and Development Collaboration with GenFleet Therapeutics

Share on Social Networks: